Anticoagulant and Antiplatelet Therapies
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Enlicitide Decanoate Data Show Significant LDL-C Reductions in At-Risk Patients
2
FDA Approves Tarlatamab-Dlle to Treat Adults With Extensive Stage Small Cell Lung Cancer
3
Newly Approved Specialty Drugs Advance Care for Inflammatory and Autoimmune Diseases
4
FDA Approves Sevabertinib for HER2-Mutant Non-Small Cell Lung Cancer
5
